Rapamycin in Relapsed Acute Lymphoblastic Leukemia

Clinical Trial ID NCT00874562

PubWeight™ 2.49‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00874562

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Big data: the next frontier for innovation in therapeutics and healthcare. Expert Rev Clin Pharmacol 2014 0.97
2 A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program. Leukemia 2016 0.76
3 Drug repurposing a reality: from computers to the clinic. Expert Rev Clin Pharmacol 2013 0.76
Next 100